Kutatási jelek – Signal Engine

• Spontaneous tumor regression and immunotherapy response demonstrate clonal T-cell expansion in Merkel cell carcinoma — Merkel cell carcinoma
• A Randomized Phase II Trial of Combined Nivolumab and Ipilimumab with or without Stereotactic Body Radiation Therapy for Advanced Merkel Cell Carcinoma — Merkel cell carcinoma
• Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study — Adenoid cystic carcinoma
• Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System — Malignant pleural mesothelioma
• Systemic and Targeted Therapies in Adenoid Cystic Carcinoma — NSCLC
• Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis — Chronic myeloid leukemia
• The focus clinical research in intrahepatic cholangiocarcinoma — Cholangiocarcinoma
• Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network — Chronic myeloid leukemia
• Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line — Breast cancer
• The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma — Cholangiocarcinoma
• Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe — Malignant pleural mesothelioma
• Endometrial cancer — Endometrial cancer
• Targeting KRAS mutant cancers: from druggable therapy to drug resistance — NSCLC
• Lung Cancer Treatment Advances in 2022. — NSCLC
• Gynecologic Cancer InterGroup Consensus Recommendations on Clinical Research in Ovarian Cancer — Ovarian cancer
• Nimotuzumab Plus Gemcitabine for K‑Ras Wild‑Type Locally Advanced or Metastatic Pancreatic Cancer — Pancreatic cancer
• Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer — SCLC
• Adagrasib in Non‑Small‑Cell Lung Cancer Harboring a KRAS(G12C) Mutation — NSCLC
• Colorectal Cancer: An Overview — Colorectal cancer
• Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database — Pancreatic cancer